Sally Goudreau
Papers
7
Total Citations
132
H-Index
4
About
Sally Goudreau is a radiation oncologist whose research has meaningfully advanced the field of breast cancer radiotherapy, with a particular focus on stereotactic partial breast irradiation (S-PBI) for early-stage disease. Her most significant contributions center on accelerated, hypofractionated radiation techniques that reduce treatment burden for patients following lumpectomy, investigating both 5-fraction and single-fraction stereotactic approaches using robotic delivery systems. Her 2017 phase 1 dose-escalation trial examining 5-fraction S-PBI has garnered 66 citations, establishing foundational safety and feasibility data that informed subsequent multi-institutional work. Goudreau has also contributed practical innovations to the field, including a refined ultrasound-guided technique for placing gold fiducial markers in postlumpectomy patients, helping ensure precise tumor bed targeting during stereotactic treatment. Her cosmetic outcomes research further demonstrates a commitment to patient-centered care, rigorously documenting aesthetic results alongside clinical endpoints. By leading and contributing to prospective phase 1 trials across multiple institutions, Goudreau has helped build the clinical evidence base needed to potentially bring shorter, more convenient radiation regimens to broader populations of breast cancer patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7